Weight loss alone does not explain all of the cardiovascular benefits observed with semaglutide 2.4 mg in the SELECT trial, ...

Novo Nordisk’s centre has become crucial to R&D and supply chain management ...

Is it still profitable even with a criminal record? ... Unfair advertising rampant in 'short-form' videos Footage judged to ...

When everyone seems to be taking GLP-1 medications, conversations about eating less and losing weight can stir up old eating ...

Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.

Three big bets in metabolic disease: the race to challenge Lilly and Novo, a pill that mimics exercise, and a gene therapy ...

Ultimately, counting calories is not about punishing the body for eating. It is about understanding what the body needs, ...

A nationwide Danish study found about half of people who started semaglutide for weight loss stopped within 12 months. Who stops, why, and what happens next.

CDW Canada, a leading provider of end-to-end technology solutions and services for Canadian organizations, announced today ...

Today's Dylan Dreyer and Craig Melvin got into a hilarious on-air exchange after Dreyer asked Melvin if he’s taking any weight loss medications: “You thought I was being judgy.” ...

Tonight on WPBS Weekly Inside the Stories, a pilot program is making popular weight loss drugs more affordable. We'll explain ...